Nivolumab with chemotherapy for untreated unresectable or metastatic urothelial cancer [ID5102]

  • In development
  • GID-TA11010
  • Expected publication date: TBC

29667-Nivolumab-Chemotherapy-for-Urothelial-Cancer-V1.0-FEB2022-NON-CONF.pdf (nihr.ac.uk)